Vytorin

Vytorin

(vī′tə-rĭn)
A trademark for a combination of the drugs simvastatin and ezetimibe.
References in periodicals archive ?
Parker has contributed to several national, high profile cases such as the 1993 World Trade Center Bombing litigation; the mass tort litigation involving Fen-Phen, an anti-obesity medication linked to causing fatal pulmonary hypertension and heart valve problems, which resulted in legal damages of over $20 billion; the Rezulin litigation; the Zyprexa Multi-District litigation; the Ortho Evra Products Liability litigation; the Kugel Mesh Multi-District litigation; the Bausch & Lomb ReNu with MoistureLoc litigation; Vytorin Multi-District litigation; the toxic Chinese-Manufactured Drywall Multi-District litigation; and the Kaba Keyless Pushbutton Locks Multi-District litigation.
Merck will seek Food and Drug Administration approval for Vytorin use in patients with chronic kidney disease (CKD) based on the SHARP trial results, the company said.
We would expect Zetia and Vytorin prescriptions to show further declines.
WASHINGTON -- The House Energy and Commerce Committee wants the Food and Drug Administration to turn over the results of an analysis about the potential links between cancer and the cholesterol drug Vytorin, which is sold jointly by Merck & Co.
prescribing information for ZOCOR and VYTORIN reflecting the changes regarding the 80 mg dose of simvastatin and the drug interaction updates are posted at www.
1 billion when it was announced in March, would unite the makers of the cholesterol drugs Zetia and Vytorin.
An immediate independent analysis of cancer incidence and mortality among 20,000 patients treated so far in two other ongoing Vytorin trials, SHARP (the Study of Heart and Renal Protection) and IMPROVE-IT (the Improved Reduction of Outcomes: Vytorin Efficacy International Trial), found no increased risk, but doubts have remained.
WASHINGTON -- A congressional committee investigating whether the marketers of the cholesterol drug Vytorin withheld data that would hurt sales has released new evidence that critics contend supports such suspicions.
In a new investigational study of VYTORIN([R])(ezetimibe/simvastatin), the cholesterol-lowering medicine from Merck (known as MSD outside the US and Canada), VYTORIN 10/20 mg reduced the incidence of first major vascular events -- defined as non-fatal heart attacks or cardiac death, stroke or any revascularization procedure -- by a highly statistically significant 16.
s cholesterol drug Vytorin (ezetimibe/simvastatin), which generated U.
Vytorin had annual sales of approximately $678 million in the U.
M2 EQUITYBITES-April 27, 2017-Impax passes US FDA approval for generic Vytorin ezetimibe/simvastatin tablets